openPR Logo
Press release

Ibogaine by David Dardashti Announces Opening of Second Clinic with Expanded, Holistic Care Model

09-23-2025 02:00 AM CET | Health & Medicine

Press release from: ABNewswire

Ibogaine by David Dardashti Announces Opening of Second Clinic

SWEETWATER, FL - Sep 22, 2025 - Ibogaine by David Dardashti, a leading provider of ibogaine-assisted therapy, is pleased to announce the opening of its second, state-of-the-art facility. This expansion represents a significant evolution in the clinic's treatment philosophy, broadening its focus beyond traditional addiction recovery to provide a more holistic approach to health and wellness.

The new clinic will offer tailored treatment protocols to address a range of patient needs, from substance use disorders to non-addiction-related issues such as trauma and depression. The existing facility will now be exclusively dedicated to the complex challenges of addiction, including the treatment of highly potent substances like fentanyl.

Innovations in Patient and Family Support

In a groundbreaking new initiative, the clinic will now allow patients the option of bringing a family member to help offer support during treatment. This unique addition to the care model recognizes the crucial role a strong support system plays in the healing journey. By involving a loved one, the clinic aims to foster a more connected and sustainable path to recovery.

Enhanced Medical and Therapeutic Staff

To support this expanded mission, the clinic has significantly increased its team of medical professionals. The addition of dedicated medical staff at both facilities is a necessary step to ensure that all patients receive the highest level of care. This commitment to a medically supervised environment is paramount, especially given the psychoactive nature of ibogaine and the need for careful patient screening and monitoring.

About Ibogaine by David Dardashti

Founded 21 years ago, Ibogaine by David Dardashti has been a pioneer in the field of ibogaine therapy, providing safe, medically supervised treatment for thousands of individuals. The organization is committed to ethical practice, patient safety, and advancing the understanding of ibogaine's therapeutic potential for a wide range of conditions.

Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ibogaine-by-david-dardashti-announces-opening-of-second-clinic-with-expanded-holistic-care-model]
Country: United States
Website: http://www.ibogaineclinic.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ibogaine by David Dardashti Announces Opening of Second Clinic with Expanded, Holistic Care Model here

News-ID: 4192867 • Views:

More Releases from ABNewswire

SEO Agency Dubai: How Data-Driven Search Strategies Are Shaping Digital Growth
SEO Agency Dubai: How Data-Driven Search Strategies Are Shaping Digital Growth
Explore how a data-driven SEO agency in Dubai helps businesses grow online through advanced search strategies, analytics, and performance-based SEO. Visit us today! Dubai's digital economy is moving fast, and visibility has become a decisive factor in growth. Businesses competing in saturated markets can no longer rely solely on paid ads. They need organic authority, credibility, and long-term discoverability. This is where an SEO agency Dubai [https://www.google.com/search?SEO+agency+Dubai&kgmid=/g/11v3f6wqbl] businesses trust becomes essential,
The Life and Loves of an Artist Illuminates the Remarkable Journey Behind a Life Shaped by Creativity, Family, and Perseverance
The Life and Loves of an Artist Illuminates the Remarkable Journey Behind a Life …
Authors Paul and Gail King present The Life and Loves of an Artist. This sweeping biographical narrative traces the extraordinary story of a family whose lives were intertwined with art, resilience, and history. Rooted in meticulous research and personal reflection, the book offers a moving portrait of two generations shaped by both hardship and inspiration. Purpose of the Book What started as an attempt to remember family memories became a vivid journey of
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 2034, analyses DelveInsight
Alzheimer's Disease Market in the 7MM is projected to reach USD 34 Billion by 20 …
Key players operating in the Alzheimer's disease market include Eisai, Biogen, Changchun Huayang High-tech Co. Ltd., Hoffmann-La Roche, vTv Therapeutics, AZTherapies, Cerecin, Neurotrope, Lyndra, AC Immune, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Prilenia Therapeutics, Denali Therapeutics Inc., Stemedica Cell Technologies, Inc., along with several other emerging and established companies. The Alzheimer's disease market was valued at approximately USD 3,610 million
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and 15+ Emerging Therapies Shaping Growth, estimates DelveInsight
Glaucoma Market Forecast 2034: USD 4,073 Million Market Size, 30+ Companies, and …
Major Glaucoma players include Allergan (AbbVie), Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., Alcon, D. Western Therapeutics Institute (DWTI), Kowa Ltd., Senju Pharmaceuticals, Otsuka Pharmaceuticals, Bausch and Lomb, Novartis, Merck & Co., Aerie Pharmaceuticals, Nicox Ophthalmics, Sylentis, Envisia Therapeutics, Ocuphire Pharma, TearClear, Peregrine Ophthalmic, and others. The Glaucoma Market across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom,

All 5 Releases


More Releases for Ibogaine

Ibogaine by David Dardashti to Illuminate the Transformative Ibogaine Experience …
DENVER, CO - June 20, 2024 - Ibogaine by David Dardashti, a pioneer in holistic Ibogaine therapy, is proud to announce its prominent participation on Day 2 of the highly anticipated Psychedelic Conference 2025. David Dardashti and his team will offer individual descriptions of the unique Ibogaine experience, providing invaluable insights for each and every person at the conference seeking information regarding profound and lasting healing from addiction, trauma, and
Ibogaine By David Dardashti is Pioneering Brain Wave Research in Ibogaine Treatm …
Renowned ibogaine expert David Dardashti is embarking on groundbreaking research measuring brain wave activity before and after ibogaine treatment. This study aims to shed light on ibogaine's impact on brain function and its potential to promote a more balanced and fulfilling life. Brain waves are electrical impulses that are produced by the brain and can be measured using an electroencephalogram (EEG). There are four main types of brain waves: alpha, beta,
Ibogaine By David Dardashti Initiates Ibogaine Data Storage on Google Cloud
Ibogaine By David Dardashti a leading psychedelic treatment center, today announced the commencement of ibogaine patient data storage and analysis on the Google Cloud platform. This initiative aims to leverage machine learning to enhance the precision and safety of ibogaine dosing based on past patient outcomes. Ibogaine, a naturally occurring psychoactive substance, has shown promise in treating opioid addiction and other mental health conditions. However, its administration requires careful dosing due
Ibogaine by David Dardashti Offers Proprietary Software to Accelerate Ibogaine R …
Ibogaine by David Dardashti, a renowned pioneer in ibogaine treatment and research, has recently made an exciting announcement regarding the availability of its proprietary software. This software is being offered to contribute to the donations made by Google co-founder towards ibogaine research specifically focused on traumatic brain injury. This potential for collaboration between Ibogaine by David Dardashti and Google co-founder's donations signifies a significant step forward in the field of ibogaine
Ibogaine By David Dardashti's Ibogaine Therapy Revolutionized by Questineers' SQ …
Ibogaine By David Dardashti, a leading innovator in the field of ibogaine therapy, today announced a groundbreaking advancement in the optimization of his ibogaine treatment software. Dardashti's software has revolutionized the way patient data is analyzed by utilizing the power of SQL. Instead of manually sifting through mountains of data, healthcare providers can now simply ask the software specific questions to extract the information they need. This streamlined approach not only
Ibogaine By David Dardashti Incorporates SQL into Ibogaine Software for Enhanced …
Ibogaine By David Dardashti, a leading provider of innovative solutions in the field of ibogaine therapy, today announced the integration of SQL (Structured Query Language) into its proprietary ibogaine software. This development marks a significant step forward in leveraging the power of data analysis to optimize the ibogaine algorithm for enhanced treatment outcomes With the integration of SQL, Ibogaine By David Dardashti has significantly enhanced its ability to analyze a vast